Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 352.75
+4.05 (1.16%)
At close: Oct 9, 2025
Biocon Revenue
Biocon had revenue of 39.42B INR in the quarter ending June 30, 2025, with 14.83% growth. This brings the company's revenue in the last twelve months to 157.71B, up 6.80% year-over-year. In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B with 3.43% growth.
Revenue (ttm)
157.71B
Revenue Growth
+6.80%
P/S Ratio
2.99
Revenue / Employee
9.67M
Employees
16,315
Market Cap
471.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,576.88B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Bajaj Finance | 387.76B |
| Infosys | 1,672.76B |
Biocon News
- 3 days ago - Biocon subsidiary, in partnership with Carnegie Pharmaceuticals, gets USFDA tentative nod for Rifaximin Tablets 550 mg - Business Upturn
- 3 days ago - Equillium (EQ) Ends Collaboration with Biocon on Itolizumab - GuruFocus
- 9 days ago - Biocon Biologics secures U.S. launch for Bosaya and Aukelso following settlement with Amgen - Business Upturn
- 13 days ago - Not a med emergency: Generic pharma cos spared from harm - The Times of India
- 14 days ago - Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street - The Times of India
- 14 days ago - Biocon shares fall over 3% after Trump’s pharma tariff announcement - Business Upturn
- 15 days ago - How To Fix Bengaluru's Civic Problem? Kiran Mazumdar Shaw Speaks To NDTV - NDTV
- 21 days ago - Top stocks to watch today, September 19: Adani Group, NTPC, JSW Energy, Vedanta, Biocon, Waaree Energies and more - Business Upturn